SMTL ID : 2eu2.1

Human Carbonic Anhydrase II in complex with novel inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.15 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: H.94, H.96, H.119 Ligands: 5DS.2 2 PLIP interactions: 2 interactions with chain A Metal complexes: A:H.94, A:H.119

1 x 5DS: (R)-1-AMINO-1-[5-(DIMETHYLAMINO)-1,3,4-THIADIAZOL-2-YL]METHANESULFONAMIDE(Non-covalent)

5DS.2: 10 residues within 4Å: Chain A: Q.92, H.94, H.96, H.119, V.121, F.130, L.197, T.198, T.199 Ligands: ZN.1 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:Q.92, A:T.198, A:T.198, A:T.199 Water bridges: A:N.67, A:H.94

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fisher, S.Z. et al., X-ray crystallographic studies reveal that the incorporation of spacer groups in carbonic anhydrase inhibitors causes alternate binding modes. Acta Crystallogr.,Sect.F (2006)

Release Date

2006-07-11

Peptides

Carbonic anhydrase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Carbonic anhydrase 2

Related Entries With Identical Sequence